Matthew Peel Latest News criminal justice act, custody nurse, custody paramedic, detention, FNE, forensic examination, Forensic healthcare, Forensic Nurse Examiner, mental health, PACE, police, Police custody, rape, SANE, SARC, sexual assault, sexual assault examination
Matthew Peel Latest News criminal justice act, custody nurse, custody paramedic, detention, evidence, FNE, forensic examination, Forensic healthcare, forensic integrity, forensic nurse, Forensic Nurse Examiner, forensic paramedic, forensic science, forensic stately, mental health, nurse, PACE, paramedic, police, Police custody, rape, samples, SANE, SARC, sexual assault, sexual assault examination, Sexual assault nurse examiner
This cross-government Victims Strategy sets out a criminal justice system-wide response to improving the support offered to victims of crime and incorporates actions from all criminal justice agencies, including the police, Criminal Prosecution Service and courts.
This strategy builds on the good progress the Government has made over the past few years to ensure victims have the right help in the aftermath of a crime and are properly supported in the process of seeing justice delivered.
The Government’s vision is for a justice system that supports even more victims to speak up by giving them the certainty that they will be understood, that they will be protected, and that they will be supported throughout their journey, regardless of their circumstances or background.
FFLM | Faculty of Forensic & Legal Medicine Consent from children and young people in police custody in England and Wales for medical examinations
The Faculty of Forensic and Legal Medicine have published guidance for clinicians working in forensic healthcare, specifically police custody, on the therapeutic and forensic considerations for children and young adults.
The legal position of children and young people under the age of 18 years (the legal upper limit of childhood) is different to that of those over 18 years. This legal difference applies to consent to, and refusal of, treatment and examination by child detainees, i.e. those under the age of 18 years. In this document, the terms ‘child’ and ‘young person’ are used interchangeably.
Matthew Peel Latest News criminal justice act, Crisis, custody nurse, custody paramedic, detention, Forensic healthcare, mental health, PACE, police, Police custody, Self-Harm, sexual offences, Suicide
This report published by the Independent Office for Police Conduct presents figures on deaths during or following police contact that happened between 1 April 2017 and 31March 2018. It provides a definitive set of figures for England and Wales, and an overview of the nature and circumstances in which these deaths occurred.
This publication is the fourteenth in a series of statistical reports on this subject, published annually by the Independent Office for Police Conduct, formerly the Independent Police Complaints Commission (IPCC). On January 8 2018, IPCC became the Independent Office for Police Conduct. This change was set out in the Policing and Crime Act 2017. The change was made because the IPCC had double in size since 2013, taking on six times as many investigations – and we asked the Government for structural changes to better suit our much-expanded organisation. To produce these statistics, the IOPC examines the circumstances of all deaths that are referred to us. We decide whether the deaths meet the criteria for inclusion in the report under one of the following categories:
- road traffic fatalities
- fatal shootings
- deaths in or following police custody> apparent suicides following police custody
- other deaths following police contact that were subject to an independent investigation
This month sees the Faculty of Forensic and Legal Medicine‘s (FFLM) publication ‘Recommendations for the collection of forensic specimens from complainants and suspects‘ for the collection of forensic specimens updated. The Forensic Science Sub-Committee, which UKAFN is represented, meets every six months to review and revise the recommendations as appropriate.
The Forensic Science Sub-Committee also considers questions sent in by members of FFLM and other interested parties, including UKAFN members. Here are the questions with answers from the last six months.
Check your email inbox for this Summers UKAFN newsletter . The newsletter has been emailed to all members. UKAFN have moved to using MailChimp to send out the newsletters, if you have not received your newsletter email, firstly please check your ‘Junk’ email folder, if still not received an email please contact UKAFN.
This edition includes;
Alcohol withdrawal Pathophysiology
Taken with consent – Medical photography
Farewell to Steve McKean
Sexual offensive focus
Police custody focus
Competitions to be won
Members can access the newsletter in the ‘Members only area’
The Department of Health and Social Care asked Lancashire Care Foundation Trust to develop an implementation pack to support services in developing, implementing and embedding routine enquiry about adversity in childhood (REACh). The implementation pack was piloted by 3 services in north-west England. The report presents findings from the pilot study.
Members can access the full document in the members are ‘Knowledge Base’
The European Drug Report 2018: Trends and Developments provides a timely insight into Europe’s drug problems and responses. The European Monitoring Centre for Drug and Drug Addiction (EMCDDA) flagship report is built on a thorough review of European and national data that highlights emerging patterns and issues. This year it is accompanied online by 30 Country Drug Reports and resources containing full data arrays and graphics, allowing an overview for each country.
Michael Linnell of Linnell Communications (www.michaelllinnell.org.uk) has provided a brief summary.
Overall internet sales have ensured Europe is now in a global market.
Cocaine. Indications are that cocaine supply has increased along with purity, with signs of rising use and an increase in cocaine users seeking treatment.
Fentanyl and new opioids: Five fentanyl derivatives were investigated in 2017. These substances were available in a number of novel forms including nasal sprays. They were also sometimes found mixed with other drugs, such as heroin, cocaine or fake medicines, with the consequence of users often being unaware that they were consuming the substance. Overall, 38 new opioids have been detected on Europe’s drug market since 2009 — including 13 reported for the first time in 2017. This includes 28 fentanyl derivatives, 10 of which were reported for the first time in 2017.
Synthetic cannabinoids: are increasingly linked to health problems and the largest group of new substances monitored by the EMCDDA and are becoming increasingly chemically diverse, with 179 detected since 2008 — including 10 reported in 2017. In the United Kingdom, use of synthetic cannabinoids among prisoners is of particular concern. A survey conducted in 2016 in UK prisons found 33 % of the 625 inmates reported the use of ‘Spice’ in the last month; in comparison, 14 % reported last month cannabis use.
Naloxone: Responding to opioid overdose: the role of naloxone Prisons: an important setting for implementing responses.
Heroin: seizures in terms of quantity declines. The discovery of several laboratories for converting morphine to heroin in the Netherlands, Spain and the Czech Republic in recent years suggests that some heroin is manufactured in Europe. According to available trend data, the number of first-time heroin clients more than halved from a peak in 2007 to a low point in 2013 before stabilising in recent years.
Overdose: It is estimated that at least 7,929 overdose deaths, involving one or more illicit drug, occurred in the European Union in 2016. This rises to an estimated 9,138 deaths if Norway and Turkey are included, representing a 4 % increase from the revised 2015 figure of 8,749; the EU situation is overall stable compared with 2015. As in previous years, the United Kingdom (34 %) and Germany (15 %) together account for around half of the European total. The most recent data show an increase in the number of heroin-related deaths in Europe, notably in the United Kingdom, where the majority of overdose deaths (87 %) involved some form of opioid.
MDMA: increased production and seizures. Until recently, in many countries, MDMA prevalence had been on the decline from peak levels attained in the early to mid-2000s. In recent years, however, monitoring sources suggest stabilisation or increased use of MDMA in some countries.
Other drugs: ketamine and GHB remain low: Seizures of other illicit drugs are reported in the European Union, including around 1,800 seizures of LSD (lysergic acid diethylamide) in 2016, amounting to 97, 000 units. The overall number of LSD seizures has almost doubled since 2010, although the quantity seized has fluctuated.
New benzodiazepines: The EMCDDA is currently monitoring 23 new benzodiazepines — 3 of which were detected for the first time in Europe in 2017. Some new benzodiazepines are sold as tablets, capsules or powders under their own names. In other cases, counterfeiters use these substances to produce fake versions of commonly prescribed anti-anxiety medicines, such as diazepam and alprazolam, which are sold directly on the illicit drug market. While the number of seizures of benzodiazepines decreased in 2016 compared with 2015, the quantity seized increased significantly. During 2016, more than half a million tablets containing new benzodiazepines such as diclazepam, etizolam, flubromazolam, flunitrazolam and fonazepam were seized — an increase of about two-thirds on the number reported in 2015.
Members can access the full document in the ‘Knowledge base’
The Greater Manchester Drug Alert Panel has issued the warning below ahead of the festival season this summer and in light of a number of recent local incidents. The Alert panel decided on a generic warning of the potency of MDMA currently in circulation rather than about any specific pills or powders as there are so many different pills of high potency in circulation. While this alert if from Manchester is it likely high potency MDMA is being circulated wider across the UK.
Please give consideration to displaying in your patient facing areas, or making available for patients to take away with them.